Albright axes 200 UK jobs as profits are hit
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.ALBRIGHT & WILSON, the chemicals group being stalked by two suitors, is to axe 10 per cent of UK staff in two years in an effort to fight a sharp downturn in several key markets.
The company, which this week received a pounds 408m bid from US rival Albemarle and also had an approach from Rhodia of France, is preparing to cut around 200 of its 1,800-strong British workforce at a cost of pounds 1.2m.
The job losses are likely to be spread among A&W's four plants in Avonmouth, Birmingham, Manchester and Cumbria. Insiders said that about 50 people had already been told they were to lose their jobs.
The redundancies follow last year's sweeping restructuring, which cost pounds 1.2m and caused the departure of 200 people.
Paul Rocheleau, the chief executive, said the measures were needed to cut costs in the face of tough trading conditions.
The UK business of A&W, which makes phosphates for detergents and carbonated drinks, had been hit hard by the strength of the pound, the loss of major customers and a slump in exports to Asia-Pacific, he added.
"These measures are very painful, but we have to reflect the economic reality we are in," he said. Mr Rocheleau pointed out that A&W's final results yesterday underlined the company's plight.
Pre-tax profit suffered a pounds 13m hit from the pound and the Asian crisis and fell by 20 per cent to pounds 48.3m. The chief executive said trading in 1999 would remain tough as there were "few signs that the economic climate and market conditions... will show any near-term improvement".
Despite Mr Rocheleau's downbeat comments, industry experts believe that Rhodia or another bidder could trump Albemarle's agreed 130p-a-share cash offer.
Rhodia, owned by the drug company Rhone-Poulenc, yesterday said that it was still considering whether to launch a counterbid.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments